EPO BERLIN-BUCH

EPO is a preclinical contract research organization (CRO) founded in 1997 as a spin-off from the Max-Delbrück-Center for Molecular Medicine [MDC] in Berlin Buch. Since then, EPO has grown steadily and today has more than 450 customers worldwide, including large pharmaceutical and biotech firms and research laboratories from world-renowned universities and institutions. The company currently employs around 50 people, more than 20 of whom hold a PhD, and is led by Dr. Jens Hoffmann (CEO) and Prof. Dr. Wolfgang Walther (CSO). EPO is based in the Karl-Lohmann-Building on the Research Campus Berlin Buch with over 1300 m² (12.000 sqf) of laboratory space. The research campus Berlin-Buch is located in the north-east of Berlin and houses research institutes, hospitals and several biotech companies... Based on its 25 years of experience, EPO is offering customized and comprehensive preclinical oncology and immuno-oncology services for the development of novel anti-cancer drugs. Our portfolio..

Also known as: EPO, EPO Berlin-Buch GmbH

Registration numbers: HR B 61814 (W)

Primary location: Buch Germany